TY - JOUR
T1 - Distinct epigenetic regulation of tumor suppressor genes in putative cancer stem cells of solid tumors
AU - Yasuda, Hiroyuki
AU - Soejima, Kenzo
AU - Watanabe, Hideo
AU - Kawada, Ichiro
AU - Nakachi, Ichiro
AU - Yoda, Satoshi
AU - Nakayama, Sohei
AU - Satomi, Ryosuke
AU - Ikemura, Shinnosuke
AU - Terai, Hideki
AU - Sato, Takashi
AU - Suzuki, Sadafumi
AU - Matsuzaki, Yumi
AU - Naoki, Katsuhiko
AU - Ishizaka, Akitoshi
PY - 2010/12
Y1 - 2010/12
N2 - Epigenetic gene regulation plays essential roles in differentiation of embryonic and tissue stem cells. In these benign undifferentiated cells, some polycomb targeted genes are kept in a state of DNA hypomethylation and they have a distinct chromatin signature termed bivalent chromatin structure to maintain their plasticity. We hypothesized that cancer stem cells (CSC), the malignant counterpart of these cells, are also under the control of epigenetics like benign stem cells. We compared the DNA methylation and chromatin structure in 10 tumor suppressor genes between CSC and differentiated cancer cells of MCF7 and Huh7 cells. We found that the level of DNA methylation was indeed significantly lower in CSC, while surprisingly, the bivalent chromatin structure was more ubiquitously seen in differentiated cancer cells compared to CSC. However, repressive marks of chromatin structure, namely H3K27me3 and EZH2, were significantly lower in CSC. As a consequence, CSC remained in a higher transcriptionally active chromatin state compared to differentiated cancer cells. We found that the differentiation of CSCs is also epigenetically regulated. These findings could help towards a comprehensive understanding of CSC, and also improve the development of eradicative therapies against human malignancies.
AB - Epigenetic gene regulation plays essential roles in differentiation of embryonic and tissue stem cells. In these benign undifferentiated cells, some polycomb targeted genes are kept in a state of DNA hypomethylation and they have a distinct chromatin signature termed bivalent chromatin structure to maintain their plasticity. We hypothesized that cancer stem cells (CSC), the malignant counterpart of these cells, are also under the control of epigenetics like benign stem cells. We compared the DNA methylation and chromatin structure in 10 tumor suppressor genes between CSC and differentiated cancer cells of MCF7 and Huh7 cells. We found that the level of DNA methylation was indeed significantly lower in CSC, while surprisingly, the bivalent chromatin structure was more ubiquitously seen in differentiated cancer cells compared to CSC. However, repressive marks of chromatin structure, namely H3K27me3 and EZH2, were significantly lower in CSC. As a consequence, CSC remained in a higher transcriptionally active chromatin state compared to differentiated cancer cells. We found that the differentiation of CSCs is also epigenetically regulated. These findings could help towards a comprehensive understanding of CSC, and also improve the development of eradicative therapies against human malignancies.
KW - Cancer stem cells
KW - DNA methylation
KW - Epigenetics
UR - http://www.scopus.com/inward/record.url?scp=78649933327&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=78649933327&partnerID=8YFLogxK
U2 - 10.3892/ijo-00000807
DO - 10.3892/ijo-00000807
M3 - Article
C2 - 21042723
AN - SCOPUS:78649933327
SN - 1019-6439
VL - 37
SP - 1537
EP - 1546
JO - International journal of oncology
JF - International journal of oncology
IS - 6
ER -